APA ציטוט

Younes, A., Santoro, A., Shipp, M., Zinzani, P. L., Timmerman, J. M., Ansell, S., . . . Engert, A. (2016). Nivolumab for classical Hodgkin lymphoma after autologous stem-cell transplantation and brentuximab vedotin failure: A prospective phase 2 multi-cohort study. Lancet Oncol.

Citação norma Chicago

Younes, Anas, et al. "Nivolumab for Classical Hodgkin Lymphoma After Autologous Stem-cell Transplantation and Brentuximab Vedotin Failure: A Prospective Phase 2 Multi-cohort Study." Lancet Oncol 2016.

ציטוט MLA

Younes, Anas, et al. "Nivolumab for Classical Hodgkin Lymphoma After Autologous Stem-cell Transplantation and Brentuximab Vedotin Failure: A Prospective Phase 2 Multi-cohort Study." Lancet Oncol 2016.